Mark Turner, Athanasia Papadimitriou, Peter Winkle, Nathan Segall, Michael Levin, Matthew Doust, . . . Derek Wallace. (2020). Immunogenicity and safety of lyophilized and liquid dengue tetravalent vaccine candidate formulations in healthy adults: A randomized, phase 2 clinical trial. Taylor & Francis Group.
Chicago Style (17th ed.) CitationMark Turner, et al. Immunogenicity and Safety of Lyophilized and Liquid Dengue Tetravalent Vaccine Candidate Formulations in Healthy Adults: A Randomized, Phase 2 Clinical Trial. Taylor & Francis Group, 2020.
MLA (9th ed.) CitationMark Turner, et al. Immunogenicity and Safety of Lyophilized and Liquid Dengue Tetravalent Vaccine Candidate Formulations in Healthy Adults: A Randomized, Phase 2 Clinical Trial. Taylor & Francis Group, 2020.